118 related articles for article (PubMed ID: 15246539)
1. Opposite conditioned place preference responses to endomorphin-1 and endomorphin-2 in the mouse.
Wu HE; MacDougall RS; Clithero AD; Leitermann RJ; Terashvili M; Tseng LF
Neurosci Lett; 2004 Jul; 365(3):157-61. PubMed ID: 15246539
[TBL] [Abstract][Full Text] [Related]
2. Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
Neuroscience; 2001; 105(1):213-8. PubMed ID: 11483313
[TBL] [Abstract][Full Text] [Related]
3. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
Kamei J; Zushida K; Ohsawa M; Nagase H
Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
[TBL] [Abstract][Full Text] [Related]
4. Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat.
Terashvili M; Wu HE; Leitermann RJ; Hung KC; Clithero AD; Schwasinger ET; Tseng LF
J Pharmacol Exp Ther; 2004 May; 309(2):816-24. PubMed ID: 14755004
[TBL] [Abstract][Full Text] [Related]
5. The antitussive effects of endomorphin-1 and endomorphin-2 in mice.
Kamei J; Morita K; Saitoh A; Nagase H
Eur J Pharmacol; 2003 Apr; 467(1-3):219-22. PubMed ID: 12706478
[TBL] [Abstract][Full Text] [Related]
6. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T
Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771
[TBL] [Abstract][Full Text] [Related]
8. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.
Tseng LF; Narita M; Suganuma C; Mizoguchi H; Ohsawa M; Nagase H; Kampine JP
J Pharmacol Exp Ther; 2000 Feb; 292(2):576-83. PubMed ID: 10640294
[TBL] [Abstract][Full Text] [Related]
9. Blockade of delta-opioid receptors prevents morphine-induced place preference in mice.
Suzuki T; Yoshiike M; Mizoguchi H; Kamei J; Misawa M; Nagase H
Jpn J Pharmacol; 1994 Sep; 66(1):131-7. PubMed ID: 7861658
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in mice.
Han ZL; Wang ZL; Tang HZ; Li N; Fang Q; Li XH; Yang XL; Zhang XY; Wang R
Behav Brain Res; 2013 Jul; 248():51-6. PubMed ID: 23578757
[TBL] [Abstract][Full Text] [Related]
11. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH
Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
[TBL] [Abstract][Full Text] [Related]
14. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
[TBL] [Abstract][Full Text] [Related]
15. Lack of the involvement of mu1-opioid receptor subtype on motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
Neurosci Lett; 2001 Jul; 308(1):17-20. PubMed ID: 11445275
[TBL] [Abstract][Full Text] [Related]
16. (+)-Morphine attenuates the (-)-morphine-produced conditioned place preference and the mu-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat.
Terashvili M; Wu HE; Schwasinger ET; Hung KC; Hong JS; Tseng LF
Eur J Pharmacol; 2008 Jun; 587(1-3):147-54. PubMed ID: 18448094
[TBL] [Abstract][Full Text] [Related]
17. Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1.
Jinsmaa Y; Marczak E; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Ambo A; Sasaki Y; Bryant SD; Okada Y; Lazarus LH
Pharmacol Biochem Behav; 2006 Jun; 84(2):252-8. PubMed ID: 16782179
[TBL] [Abstract][Full Text] [Related]
18. Endomorphin-induced motivational effect: differential mechanism of endomorphin-1 and endomorphin-2.
Narita M; Ozaki S; Suzuki T
Jpn J Pharmacol; 2002 Jul; 89(3):224-8. PubMed ID: 12184726
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.
Salmi P; Kela J; Arvidsson U; Wahlestedt C
Eur J Pharmacol; 2003 Jan; 458(1-2):101-6. PubMed ID: 12498912
[TBL] [Abstract][Full Text] [Related]
20. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
